Cannabis-based drug for epilepsy to be fast-tracked into NHS – The Guardian

Epidyolex (known in the US as Epidiolex) can reduce the number of seizures by up to 40% in children with severe forms of epilepsy.

Cannabis-based medicine is to be fast-tracked into the NHS, allowing thousands of people to be prescribed the drugs, including children with severe epilepsy.

Last month the NHS struck a deal with the manufacturer GW Pharmaceuticals to bring down the price of Epidyolex, which has been approved by the European medicines agency for use in children over the age of two who suffer from seizures associated with two rare and severe forms of epilepsy – Lennox-Gastaut syndrome (LGS) and Dravet syndrome.

Click here to read full article

Font Resize